SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1sgf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 8	HIS G 57 ASP G 189 SER G 195 GLY G 216 GLY G 226	None	0.74A	1aq7A-1sgfG: 35.9	1aq7A-1sgfG: 41.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 9	ASP G 189 SER G 195 TRP G 215 GLY G 216 GLY G 226	None	0.33A	1bcuH-1sgfG: 17.3	1bcuH-1sgfG: 32.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DWC_H_MITH1_1 (ALPHA-THROMBIN (LARGE SUBUNIT))	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 9	HIS G 57 ASP G 189 SER G 195 TRP G 215 GLY G 226	None	0.49A	1dwcH-1sgfG: 32.6	1dwcH-1sgfG: 32.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	HIS G 57 ASP G 189 SER G 195 TRP G 215 GLY G 216 GLY G 226	None	0.70A	1etrH-1sgfG: 32.2	1etrH-1sgfG: 32.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 8	ASP G 189 SER G 195 GLY G 216 GLY G 226	None	0.52A	1f5lA-1sgfG: 13.2	1f5lA-1sgfG: 34.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MEH_A_MOAA600_1 (INOSINE-5'-MONOPHOSP HATE DEHYDROGENASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 10	SER G 195 SER G 214 ILE G 212 GLY G 211 GLY G 226	None	1.29A	1mehA-1sgfG: undetectable	1mehA-1sgfG: 18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P6K_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 8	SER A 95 GLN A 95 ASN A 95 ASP A 97	NAG A 11 (-3.4A) None NAG A 11 (-2.0A) NAG A 11 (-4.2A)	1.36A	1p6kA-1sgfA: 0.0	1p6kA-1sgfA: 17.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 6	ASP G 189 SER G 195 GLY G 216 GLY G 226	None	0.45A	1tnlA-1sgfG: 36.7	1tnlA-1sgfG: 41.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZQ_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 8	SER A 95 GLN A 95 ASN A 95 ASP A 97	NAG A 11 (-3.4A) None NAG A 11 (-2.0A) NAG A 11 (-4.2A)	1.33A	1zzqA-1sgfA: undetectable	1zzqA-1sgfA: 19.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 6	ASP G 189 SER G 195 GLY G 216 GLY G 226	None	0.33A	2otvA-1sgfG: 36.8	2otvA-1sgfG: 41.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	ASP G 189 SER G 195 TRP G 215 GLY G 216 GLY G 226 TYR G 228	None	0.46A	2p16A-1sgfG: 16.8	2p16A-1sgfG: 32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	TYR G 99 ASP G 189 TRP G 215 GLY G 216 GLY G 226 TYR G 228	None	0.78A	2p16A-1sgfG: 16.8	2p16A-1sgfG: 32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 8	ASP G 189 SER G 195 GLY G 216 GLY G 226	None	0.59A	2vinA-1sgfG: 13.8	2vinA-1sgfG: 34.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	ASP G 189 SER G 195 TRP G 215 GLY G 216 GLY G 226 TYR G 228	None	0.45A	2w26A-1sgfG: 17.6	2w26A-1sgfG: 32.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	TYR G 99 ASP G 189 TRP G 215 GLY G 216 GLY G 226 TYR G 228	None	0.78A	2w26A-1sgfG: 17.6	2w26A-1sgfG: 32.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X1L_A_ADNA601_1 (METHIONYL-TRNA SYNTHETASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 11	ALA G 138 GLY G 196 GLY G 140 ILE G 16 HIS G 30	None	0.96A	2x1lA-1sgfG: undetectable	2x1lA-1sgfG: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X1L_B_ADNB601_1 (METHIONYL-TRNA SYNTHETASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	ALA G 138 GLY G 196 GLY G 140 ILE G 16 HIS G 30	None	0.93A	2x1lB-1sgfG: undetectable	2x1lB-1sgfG: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X1L_C_ADNC601_1 (METHIONYL-TRNA SYNTHETASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 11	ALA G 138 GLY G 196 GLY G 140 ILE G 16 HIS G 30	None	0.96A	2x1lC-1sgfG: undetectable	2x1lC-1sgfG: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ARU_A_PNXA608_1 (CHITINASE A)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 6	TRP G 141 SER G 139 ALA G 138 ASP G 194	None	1.17A	3aruA-1sgfG: undetectable	3aruA-1sgfG: 17.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 11	HIS G 57 ASP G 189 SER G 195 TRP G 215 GLY G 216 GLY G 226	None	0.56A	3gy3A-1sgfG: 35.5	3gy3A-1sgfG: 41.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HJO_A_EAAA211_1 (GLUTATHIONE S-TRANSFERASE P)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 8	TYR G 40 VAL G 66 TRP G 67 GLY G 44	None	0.70A	3hjoA-1sgfG: undetectable	3hjoA-1sgfG: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEE_A_30BA500_1 (GENOME POLYPROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	HIS G 57 ASP G 102 LYS G 192 GLY G 193 SER G 195	None	0.85A	3keeA-1sgfG: 11.3	3keeA-1sgfG: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEE_B_30BB500_1 (GENOME POLYPROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	HIS G 57 ASP G 102 LYS G 192 GLY G 193 SER G 195	None	0.84A	3keeB-1sgfG: 11.6	3keeB-1sgfG: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEE_C_30BC500_1 (GENOME POLYPROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	HIS G 57 ASP G 102 LYS G 192 GLY G 193 SER G 195	None	0.86A	3keeC-1sgfG: 11.0	3keeC-1sgfG: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEE_D_30BD500_1 (GENOME POLYPROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	HIS G 57 ASP G 102 LYS G 192 GLY G 193 SER G 195	None	0.82A	3keeD-1sgfG: 11.4	3keeD-1sgfG: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KMO_B_EAAB213_1 (GLUTATHIONE S-TRANSFERASE P)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 7	TYR G 40 VAL G 66 TRP G 67 GLY G 44	None	0.70A	3kmoB-1sgfG: undetectable	3kmoB-1sgfG: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RAE_F_LFXF101_1 (DNA TOPOISOMERASE 4 SUBUNIT A DNA TOPOISOMERASE 4 SUBUNIT B)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	3 / 4	SER G 26 GLY G 19 GLU G 185	None	0.47A	3raeA-1sgfG: undetectable 3raeC-1sgfG: undetectable	3raeA-1sgfG: 17.54 3raeC-1sgfG: 18.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 6	SER G 195 TRP G 215 GLY G 216 GLY G 226	None	0.39A	3rxfA-1sgfG: 15.4	3rxfA-1sgfG: 41.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUE_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	HIS G 57 ASP G 102 LYS G 192 GLY G 193 SER G 195	None	0.79A	3sueA-1sgfG: 10.3	3sueA-1sgfG: 22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUF_A_SUEA1201_1 (NS3 PROTEASE, NS4A PROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	HIS G 57 ASP G 102 LYS G 192 GLY G 193 SER G 195	None	0.87A	3sufA-1sgfG: 10.6	3sufA-1sgfG: 22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_0 (MNMC2)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	GLY G 69 LEU G 73 ASN G 71 ALA G 112 LEU G 46	None	1.21A	3vywD-1sgfG: undetectable	3vywD-1sgfG: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_D_W9TD507_1 (HEMOLYTIC LECTIN CEL-III)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	4 / 5	GLU A 173 GLY A 216 TYR A 99 ASP A 102	None	1.38A	3w9tD-1sgfA: 0.0	3w9tD-1sgfA: 18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CTK_C_SAMC1263_0 (POLYPROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	GLY G 142 GLY G 44 GLY G 196 GLY G 193 THR G 54 VAL G 52	None	1.38A	4ctkC-1sgfG: undetectable	4ctkC-1sgfG: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GC9_A_ACTA402_0 (DIMETHYLADENOSINE TRANSFERASE 1, MITOCHONDRIAL)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	3 / 3	LYS A 39 TYR A 40 ARG A 35	None	1.25A	4gc9A-1sgfA: undetectable	4gc9A-1sgfA: 21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JUO_F_LFXF101_1 (DNA TOPOISOMERASE 4 SUBUNIT A DNA TOPOISOMERASE 4 SUBUNIT B E-SITE DNA)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	3 / 4	SER G 26 GLY G 19 GLU G 185	None	0.41A	4juoA-1sgfG: undetectable 4juoC-1sgfG: undetectable	4juoA-1sgfG: 17.54 4juoC-1sgfG: 16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KY8_C_MTXC603_1 (BIFUNCTIONAL THYMIDYLATE SYNTHASE-DIHYDROFOLA TE REDUCTASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	ALA A 179 SER A 236 ILE A 238 LEU A 53 THR A 177	None	1.08A	4ky8C-1sgfA: undetectable	4ky8C-1sgfA: 18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XT8_A_TMQA302_1 (RV2671)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 12	SER A 195 ALA A 55 ASP A 102 GLU A 218 THR A 229	None	1.06A	4xt8A-1sgfA: undetectable	4xt8A-1sgfA: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EIW_C_SAMC4000_0 (NS5 METHYLTRANSFERASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	GLY G 142 GLY G 44 GLY G 196 GLY G 193 THR G 54 VAL G 52	None	1.38A	5eiwC-1sgfG: undetectable	5eiwC-1sgfG: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EKX_B_SAMB4000_0 (NS5 METHYLTRANSFERASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	GLY G 142 GLY G 44 GLY G 196 GLY G 193 THR G 54 VAL G 52	None	1.39A	5ekxB-1sgfG: undetectable	5ekxB-1sgfG: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M5B_A_SAMA1001_0 (NS5 METHYLTRANSFERASE)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	6 / 12	GLY G 142 GLY G 44 GLY G 196 GLY G 193 THR G 54 VAL G 52	None	1.39A	5m5bA-1sgfG: undetectable	5m5bA-1sgfG: 19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUG_A_VIVA301_1 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	3 / 3	SER A 214 SER A 195 PHE A 94	None	0.91A	5mugA-1sgfA: undetectable	5mugA-1sgfA: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUG_A_VIVA301_1 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	3 / 3	SER G 214 SER G 195 PHE G 94	None	0.71A	5mugA-1sgfG: undetectable	5mugA-1sgfG: 18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_A_PCFA1807_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	5 / 7	GLY A 44 LEU A 181 ILE A 121 LEU A 47 ILE A 232	None	1.34A	5vkqA-1sgfA: undetectable 5vkqB-1sgfA: undetectable	5vkqA-1sgfA: 9.27 5vkqB-1sgfA: 9.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AUU_A_ACTA804_0 (NITRIC OXIDE SYNTHASE, BRAIN)	1sgf	NERVE GROWTH FACTOR (Mus musculus)	3 / 3	GLN A 41 TRP A 67 VAL A 66	None	1.16A	6auuA-1sgfA: undetectable	6auuA-1sgfA: 18.01

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 189;SER G 195;GLY G 216;GLY G 226","None","0.74A","1aq7A-1sgfG:35.9","1aq7A-1sgfG:41.42"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"ASP G 189;SER G 195;TRP G 215;GLY G 216;GLY G 226","None","0.33A","1bcuH-1sgfG:17.3","1bcuH-1sgfG:32.23"],["1DWC_H_MITH1_1","ALPHA-THROMBIN (LARGE SUBUNIT)","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 189;SER G 195;TRP G 215;GLY G 226","None","0.49A","1dwcH-1sgfG:32.6","1dwcH-1sgfG:32.23"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"HIS G  57;ASP G 189;SER G 195;TRP G 215;GLY G 216;GLY G 226","None","0.70A","1etrH-1sgfG:32.2","1etrH-1sgfG:32.35"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"ASP G 189;SER G 195;GLY G 216;GLY G 226","None","0.52A","1f5lA-1sgfG:13.2","1f5lA-1sgfG:34.34"],["1MEH_A_MOAA600_1","INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"SER G 195;SER G 214;ILE G 212;GLY G 211;GLY G 226","None","1.29A","1mehA-1sgfG:undetectable","1mehA-1sgfG:18.81"],["1P6K_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"SER A  95;GLN A  95;ASN A  95;ASP A  97","NAG A  11 (-3.4A);None;NAG A  11 (-2.0A);NAG A  11 (-4.2A)","1.36A","1p6kA-1sgfA:0.0","1p6kA-1sgfA:17.81"],["1TNL_A_TPAA900_1","TRYPSIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"ASP G 189;SER G 195;GLY G 216;GLY G 226","None","0.45A","1tnlA-1sgfG:36.7","1tnlA-1sgfG:41.42"],["1ZZQ_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"SER A  95;GLN A  95;ASN A  95;ASP A  97","NAG A  11 (-3.4A);None;NAG A  11 (-2.0A);NAG A  11 (-4.2A)","1.33A","1zzqA-1sgfA:undetectable","1zzqA-1sgfA:19.29"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"ASP G 189;SER G 195;GLY G 216;GLY G 226","None","0.33A","2otvA-1sgfG:36.8","2otvA-1sgfG:41.42"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"ASP G 189;SER G 195;TRP G 215;GLY G 216;GLY G 226;TYR G 228","None","0.46A","2p16A-1sgfG:16.8","2p16A-1sgfG:32.41"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"TYR G  99;ASP G 189;TRP G 215;GLY G 216;GLY G 226;TYR G 228","None","0.78A","2p16A-1sgfG:16.8","2p16A-1sgfG:32.41"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"ASP G 189;SER G 195;GLY G 216;GLY G 226","None","0.59A","2vinA-1sgfG:13.8","2vinA-1sgfG:34.34"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"ASP G 189;SER G 195;TRP G 215;GLY G 216;GLY G 226;TYR G 228","None","0.45A","2w26A-1sgfG:17.6","2w26A-1sgfG:32.41"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"TYR G  99;ASP G 189;TRP G 215;GLY G 216;GLY G 226;TYR G 228","None","0.78A","2w26A-1sgfG:17.6","2w26A-1sgfG:32.41"],["2X1L_A_ADNA601_1","METHIONYL-TRNA SYNTHETASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"ALA G 138;GLY G 196;GLY G 140;ILE G  16;HIS G  30","None","0.96A","2x1lA-1sgfG:undetectable","2x1lA-1sgfG:17.42"],["2X1L_B_ADNB601_1","METHIONYL-TRNA SYNTHETASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"ALA G 138;GLY G 196;GLY G 140;ILE G  16;HIS G  30","None","0.93A","2x1lB-1sgfG:undetectable","2x1lB-1sgfG:17.42"],["2X1L_C_ADNC601_1","METHIONYL-TRNA SYNTHETASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"ALA G 138;GLY G 196;GLY G 140;ILE G  16;HIS G  30","None","0.96A","2x1lC-1sgfG:undetectable","2x1lC-1sgfG:17.42"],["3ARU_A_PNXA608_1","CHITINASE A","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"TRP G 141;SER G 139;ALA G 138;ASP G 194","None","1.17A","3aruA-1sgfG:undetectable","3aruA-1sgfG:17.99"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"HIS G  57;ASP G 189;SER G 195;TRP G 215;GLY G 216;GLY G 226","None","0.56A","3gy3A-1sgfG:35.5","3gy3A-1sgfG:41.42"],["3HJO_A_EAAA211_1","GLUTATHIONE S-TRANSFERASE P","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"TYR G  40;VAL G  66;TRP G  67;GLY G  44","None","0.70A","3hjoA-1sgfG:undetectable","3hjoA-1sgfG:22.35"],["3KEE_A_30BA500_1","GENOME POLYPROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 102;LYS G 192;GLY G 193;SER G 195","None","0.85A","3keeA-1sgfG:11.3","3keeA-1sgfG:19.20"],["3KEE_B_30BB500_1","GENOME POLYPROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 102;LYS G 192;GLY G 193;SER G 195","None","0.84A","3keeB-1sgfG:11.6","3keeB-1sgfG:19.20"],["3KEE_C_30BC500_1","GENOME POLYPROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 102;LYS G 192;GLY G 193;SER G 195","None","0.86A","3keeC-1sgfG:11.0","3keeC-1sgfG:19.20"],["3KEE_D_30BD500_1","GENOME POLYPROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 102;LYS G 192;GLY G 193;SER G 195","None","0.82A","3keeD-1sgfG:11.4","3keeD-1sgfG:19.20"],["3KMO_B_EAAB213_1","GLUTATHIONE S-TRANSFERASE P","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"TYR G  40;VAL G  66;TRP G  67;GLY G  44","None","0.70A","3kmoB-1sgfG:undetectable","3kmoB-1sgfG:22.35"],["3RAE_F_LFXF101_1","DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT B","1sgf","NERVE GROWTH FACTOR","Mus musculus",3,"SER G  26;GLY G  19;GLU G 185","None","0.47A","3raeA-1sgfG:undetectable;3raeC-1sgfG:undetectable","3raeA-1sgfG:17.54;3raeC-1sgfG:18.71"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"SER G 195;TRP G 215;GLY G 216;GLY G 226","None","0.39A","3rxfA-1sgfG:15.4","3rxfA-1sgfG:41.42"],["3SUE_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 102;LYS G 192;GLY G 193;SER G 195","None","0.79A","3sueA-1sgfG:10.3","3sueA-1sgfG:22.04"],["3SUF_A_SUEA1201_1","NS3 PROTEASE, NS4A PROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"HIS G  57;ASP G 102;LYS G 192;GLY G 193;SER G 195","None","0.87A","3sufA-1sgfG:10.6","3sufA-1sgfG:22.04"],["3VYW_D_SAMD401_0","MNMC2","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"GLY G  69;LEU G  73;ASN G  71;ALA G 112;LEU G  46","None","1.21A","3vywD-1sgfG:undetectable","3vywD-1sgfG:19.31"],["3W9T_D_W9TD507_1","HEMOLYTIC LECTIN CEL-III","1sgf","NERVE GROWTH FACTOR","Mus musculus",4,"GLU A 173;GLY A 216;TYR A  99;ASP A 102","None","1.38A","3w9tD-1sgfA:0.0","3w9tD-1sgfA:18.14"],["4CTK_C_SAMC1263_0","POLYPROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"GLY G 142;GLY G  44;GLY G 196;GLY G 193;THR G  54;VAL G  52","None","1.38A","4ctkC-1sgfG:undetectable","4ctkC-1sgfG:19.80"],["4GC9_A_ACTA402_0","DIMETHYLADENOSINE TRANSFERASE 1, MITOCHONDRIAL","1sgf","NERVE GROWTH FACTOR","Mus musculus",3,"LYS A  39;TYR A  40;ARG A  35","None","1.25A","4gc9A-1sgfA:undetectable","4gc9A-1sgfA:21.78"],["4JUO_F_LFXF101_1","DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT B;E-SITE DNA","1sgf","NERVE GROWTH FACTOR","Mus musculus",3,"SER G  26;GLY G  19;GLU G 185","None","0.41A","4juoA-1sgfG:undetectable;4juoC-1sgfG:undetectable","4juoA-1sgfG:17.54;4juoC-1sgfG:16.67"],["4KY8_C_MTXC603_1","BIFUNCTIONAL THYMIDYLATE SYNTHASE-DIHYDROFOLATE REDUCTASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"ALA A 179;SER A 236;ILE A 238;LEU A  53;THR A 177","None","1.08A","4ky8C-1sgfA:undetectable","4ky8C-1sgfA:18.48"],["4XT8_A_TMQA302_1","RV2671","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"SER A 195;ALA A  55;ASP A 102;GLU A 218;THR A 229","None","1.06A","4xt8A-1sgfA:undetectable","4xt8A-1sgfA:19.20"],["5EIW_C_SAMC4000_0","NS5 METHYLTRANSFERASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"GLY G 142;GLY G  44;GLY G 196;GLY G 193;THR G  54;VAL G  52","None","1.38A","5eiwC-1sgfG:undetectable","5eiwC-1sgfG:19.80"],["5EKX_B_SAMB4000_0","NS5 METHYLTRANSFERASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"GLY G 142;GLY G  44;GLY G 196;GLY G 193;THR G  54;VAL G  52","None","1.39A","5ekxB-1sgfG:undetectable","5ekxB-1sgfG:19.80"],["5M5B_A_SAMA1001_0","NS5 METHYLTRANSFERASE","1sgf","NERVE GROWTH FACTOR","Mus musculus",6,"GLY G 142;GLY G  44;GLY G 196;GLY G 193;THR G  54;VAL G  52","None","1.39A","5m5bA-1sgfG:undetectable","5m5bA-1sgfG:19.66"],["5MUG_A_VIVA301_1","ALPHA-TOCOPHEROL TRANSFER PROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",3,"SER A 214;SER A 195;PHE A  94","None","0.91A","5mugA-1sgfA:undetectable","5mugA-1sgfA:20.82"],["5MUG_A_VIVA301_1","ALPHA-TOCOPHEROL TRANSFER PROTEIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",3,"SER G 214;SER G 195;PHE G  94","None","0.71A","5mugA-1sgfG:undetectable","5mugA-1sgfG:18.92"],["5VKQ_A_PCFA1807_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","1sgf","NERVE GROWTH FACTOR","Mus musculus",5,"GLY A  44;LEU A 181;ILE A 121;LEU A  47;ILE A 232","None","1.34A","5vkqA-1sgfA:undetectable;5vkqB-1sgfA:undetectable","5vkqA-1sgfA:9.27;5vkqB-1sgfA:9.27"],["6AUU_A_ACTA804_0","NITRIC OXIDE SYNTHASE, BRAIN","1sgf","NERVE GROWTH FACTOR","Mus musculus",3,"GLN A  41;TRP A  67;VAL A  66","None","1.16A","6auuA-1sgfA:undetectable","6auuA-1sgfA:18.01"]]